PMGC HOLDINGS INC. Disposal Group, Including Discontinued Operation, Revenue
PMGC HOLDINGS INC. (ELAB) reported Disposal Group, Including Discontinued Operation, Revenue of $152.38 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Income Statement › Other Income
us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue · last filed 2026-08-14
- PMGC HOLDINGS INC. disposal group, including discontinued operation, revenue for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- PMGC HOLDINGS INC. disposal group, including discontinued operation, revenue for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- PMGC HOLDINGS INC. disposal group, including discontinued operation, revenue for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- PMGC HOLDINGS INC. disposal group, including discontinued operation, revenue for the quarter ending 2025-03-31 was $152.38K, a 75.20% decline year-over-year.
- PMGC HOLDINGS INC. disposal group, including discontinued operation, revenue for fiscal 2025 was $152.38K, a 93.82% decline from fiscal 2024.
- PMGC HOLDINGS INC. disposal group, including discontinued operation, revenue for fiscal 2024 was $2.47M, a 44.07% increase from fiscal 2023.
- PMGC HOLDINGS INC. disposal group, including discontinued operation, revenue for fiscal 2023 was $1.71M.
| Period end | Disposal Group, Including Discontinued Operation, Revenue 3 month | Disposal Group, Including Discontinued Operation, Revenue 6 month | Disposal Group, Including Discontinued Operation, Revenue 9 month | Disposal Group, Including Discontinued Operation, Revenue 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $0.00 derived: sum of 2 quarters · filed 2026-03-30 | $0.00 derived: sum of 3 quarters · filed 2026-08-14 | $152.38K 10-K · filed 2026-03-30 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $0.00 derived: sum of 2 quarters · filed 2026-08-14 | $152.38K 10-Q · filed 2025-11-14 | $872.11K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $152.38K 10-Q · filed 2026-08-14 | $872.11K derived: sum of 3 quarters · filed 2026-08-14 | $1.40M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $152.38K 10-Q · filed 2026-05-15 | $872.11K derived: sum of 2 quarters · filed 2026-05-15 | $1.40M derived: sum of 3 quarters · filed 2026-05-15 | $2.01M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $719.73K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $1.25M derived: sum of 2 quarters · filed 2026-03-30 | $1.85M derived: sum of 3 quarters · filed 2026-03-30 | $2.47M 10-K · filed 2026-03-30 |
| 2024-09-30 | $527.48K 10-Q · filed 2025-11-14 | $1.13M derived: sum of 2 quarters · filed 2025-11-14 | $1.75M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $605.53K 10-Q · filed 2025-08-13 | $1.22M 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | $614.56K 10-Q · filed 2025-05-14 | |||
| 2023-12-31 | $1.71M 10-K · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |